Acusensus Statistics

Total Valuation

Acusensus has a market cap or net worth of AUD 135.83 million. The enterprise value is 108.16 million.

Market Cap	135.83M
Enterprise Value	108.16M

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Acusensus has 140.03 million shares outstanding. The number of shares has decreased by -4.46% in one year.

Current Share Class	n/a
Shares Outstanding	140.03M
Shares Change (YoY)	-4.46%
Shares Change (QoQ)	+9.84%
Owned by Insiders (%)	15.33%
Owned by Institutions (%)	24.42%
Float	94.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.53
PB Ratio	2.84
P/TBV Ratio	2.84
P/FCF Ratio	112.44
P/OCF Ratio	14.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.03, with an EV/FCF ratio of 89.54.

EV / Earnings	-60.33
EV / Sales	2.02
EV / EBITDA	37.03
EV / EBIT	n/a
EV / FCF	89.54

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.06.

Current Ratio	3.13
Quick Ratio	3.00
Debt / Equity	0.06
Debt / EBITDA	0.91
Debt / FCF	2.20
Interest Coverage	-26.33

Financial Efficiency

Return on equity (ROE) is -4.25% and return on invested capital (ROIC) is -2.71%.

Return on Equity (ROE)	-4.25%
Return on Assets (ROA)	-2.15%
Return on Invested Capital (ROIC)	-2.71%
Return on Capital Employed (ROCE)	-3.79%
Revenue Per Employee	327,293
Profits Per Employee	-10,933
Employee Count	164
Asset Turnover	0.96
Inventory Turnover	16.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.57% in the last 52 weeks. The beta is -0.28, so Acusensus's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	+38.57%
50-Day Moving Average	1.10
200-Day Moving Average	0.93
Relative Strength Index (RSI)	38.51
Average Volume (20 Days)	120,709

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Acusensus had revenue of AUD 53.68 million and -1.79 million in losses. Loss per share was -0.01.

Revenue	53.68M
Gross Profit	25.05M
Operating Income	-1.92M
Pretax Income	-1.17M
Net Income	-1.79M
EBITDA	1.23M
EBIT	-1.92M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 30.31 million in cash and 2.65 million in debt, giving a net cash position of 27.66 million or 0.20 per share.

Cash & Cash Equivalents	30.31M
Total Debt	2.65M
Net Cash	27.66M
Net Cash Per Share	0.20
Equity (Book Value)	47.89M
Book Value Per Share	0.34
Working Capital	30.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.43 million and capital expenditures -8.22 million, giving a free cash flow of 1.21 million.

Operating Cash Flow	9.43M
Capital Expenditures	-8.22M
Free Cash Flow	1.21M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 46.67%, with operating and profit margins of -3.58% and -3.34%.

Gross Margin	46.67%
Operating Margin	-3.58%
Pretax Margin	-2.19%
Profit Margin	-3.34%
EBITDA Margin	2.28%
EBIT Margin	-3.58%
FCF Margin	2.25%

Dividends & Yields

Acusensus does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.46%
Shareholder Yield	4.46%
Earnings Yield	-1.32%
FCF Yield	0.89%

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 5.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	5

Scores

Acusensus has an Altman Z-Score of 4.62.

Altman Z-Score	4.62
Piotroski F-Score	n/a